Key Highlights:
- Alivira Animal Health (subsidiary of Viyash Scientific) has teamed up with Boehringer Ingelheim India to distribute and promote its companion animal healthcare products across India, tapping into the country’s rapidly growing pet healthcare market.
- The partnership brings together Alivira’s strong on-ground presence and nationwide reach with Boehringer Ingelheim’s portfolio of pet medicines, helping expand access to quality treatments for veterinarians and pet parents in both urban and rural areas.
- With pet ownership rising and awareness around preventive care increasing, both companies see the collaboration as a way to scale their companion animal business while improving availability of trusted healthcare solutions for pets across India.
Implications:
India’s pet care market reaches $3.6B in 2024, growing 20% CAGR to $24.8B by 2032; veterinary healthcare hits $1.76B by 2026 (8.64% CAGR)—partnership targets high-margin companion animal growth.
Alivira/Boehringer leverage rural/urban reach where 60% pet expansion occurs, challenging Zoetis in premium meds.
Positions India as pet export hub, eyeing Saudi/Gulf parallels
Source: Expresspharma
Other Articles
Next
Previous
No Comment! Be the first one.